FR2916973B1 - Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s) - Google Patents

Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)

Info

Publication number
FR2916973B1
FR2916973B1 FR0755652A FR0755652A FR2916973B1 FR 2916973 B1 FR2916973 B1 FR 2916973B1 FR 0755652 A FR0755652 A FR 0755652A FR 0755652 A FR0755652 A FR 0755652A FR 2916973 B1 FR2916973 B1 FR 2916973B1
Authority
FR
France
Prior art keywords
hydrodispersible
hydrosoluble
lipidic
nanocapsules
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0755652A
Other languages
English (en)
Other versions
FR2916973A1 (fr
Inventor
Patrick Saulnier
Jean Pierre Benoit
Nicolas Anton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAngers
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Universite dAngers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite dAngers filed Critical Universite dAngers
Priority to FR0755652A priority Critical patent/FR2916973B1/fr
Priority to US12/663,937 priority patent/US9333180B2/en
Priority to CA2690471A priority patent/CA2690471A1/fr
Priority to EP08805977A priority patent/EP2167053A2/fr
Priority to PCT/FR2008/051042 priority patent/WO2009001019A2/fr
Publication of FR2916973A1 publication Critical patent/FR2916973A1/fr
Application granted granted Critical
Publication of FR2916973B1 publication Critical patent/FR2916973B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
FR0755652A 2007-06-11 2007-06-11 Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s) Active FR2916973B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0755652A FR2916973B1 (fr) 2007-06-11 2007-06-11 Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
US12/663,937 US9333180B2 (en) 2007-06-11 2008-06-11 Nanocapsules with a liquid lipid core charged with water-soluble or water-dispersible active agents
CA2690471A CA2690471A1 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
EP08805977A EP2167053A2 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
PCT/FR2008/051042 WO2009001019A2 (fr) 2007-06-11 2008-06-11 Nanocapsules a coeur lipidique liquide chargees en actifs(s) hydrosoluble(s) ou hydrodispersible(s)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0755652A FR2916973B1 (fr) 2007-06-11 2007-06-11 Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)

Publications (2)

Publication Number Publication Date
FR2916973A1 FR2916973A1 (fr) 2008-12-12
FR2916973B1 true FR2916973B1 (fr) 2010-02-26

Family

ID=39046733

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0755652A Active FR2916973B1 (fr) 2007-06-11 2007-06-11 Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)

Country Status (5)

Country Link
US (1) US9333180B2 (fr)
EP (1) EP2167053A2 (fr)
CA (1) CA2690471A1 (fr)
FR (1) FR2916973B1 (fr)
WO (1) WO2009001019A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9393315B2 (en) 2011-06-08 2016-07-19 Nitto Denko Corporation Compounds for targeting drug delivery and enhancing siRNA activity
FR2939699B1 (fr) 2008-12-12 2011-05-06 Univ Angers Procede de preparation de nanoparticules lipidiques
FR2943544B1 (fr) 2009-03-31 2012-04-20 Univ Angers Procede de preparation de capsules lipidiques fonctionnalisees.
US10196637B2 (en) 2011-06-08 2019-02-05 Nitto Denko Corporation Retinoid-lipid drug carrier
FR3017294B1 (fr) 2014-02-07 2021-10-01 Atlangram Nanoparticules lipidiques comprenant un antibiotique et leurs utilisations en therapie
US11278568B2 (en) 2015-07-09 2022-03-22 Medesis Pharma In situ preparation of cyano-bridged metal nanoparticles within a biocompatible reverse micellar system
WO2017153434A1 (fr) 2016-03-07 2017-09-14 Cryovac, Inc. Film à ouverture facile pour emballage moulant sous vide
GB201721832D0 (en) 2017-12-22 2018-02-07 Waterford Institute Of Tech Ocular drug delivery
WO2020021052A2 (fr) 2018-07-27 2020-01-30 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation d'alcools terpéniques acycliques pour améliorer l'activité antimicrobienne de la colistine
EP3679928A1 (fr) 2019-01-08 2020-07-15 Atlangram Composition pharmaceutique de type gel pour traiter/prevenir une infection
EP3986374B1 (fr) * 2019-06-21 2026-01-28 Université catholique de Louvain Nanocapsules lipidiques chargées en mimétiques d'incrétine
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
FR2805761B1 (fr) 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
FR2840532B1 (fr) * 2002-06-11 2005-05-06 Ethypharm Sa Nanocapsules lipidiques furtives, procede de preparation et utilisation comme vecteur de principes(s) actif(s)
EP1955695A1 (fr) * 2007-02-06 2008-08-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nanocapsules de complexes lipophiles d'acides nucléiques
FR2916974B1 (fr) * 2007-06-11 2010-11-26 Univ Angers Procede de preparation de nanoparticules lipidiques

Also Published As

Publication number Publication date
CA2690471A1 (fr) 2008-12-31
WO2009001019A3 (fr) 2009-03-26
EP2167053A2 (fr) 2010-03-31
FR2916973A1 (fr) 2008-12-12
WO2009001019A2 (fr) 2008-12-31
US20100266676A1 (en) 2010-10-21
US9333180B2 (en) 2016-05-10

Similar Documents

Publication Publication Date Title
FR2916973B1 (fr) Nanocapsules a coeur lipidique chargees en actif(s) hydrosoluble(s) ou hydrodispersible(s)
SE0801744L (sv) Övervakning av epileptiform aktivitet
DK2346408T3 (da) Overvågning af fosterhjerteaktivitet
EP2126279A4 (fr) Moniteur de trou de forage
EP2132670A4 (fr) Agrégation du classement surveillée sur la base des classifications
EP2175714A4 (fr) Plantes transgéniques à caractéristiques agronomiques améliorées
ATE544742T1 (de) Insektizide arylpyrrolidine
BRPI0811294A2 (pt) Genes de resistência a herbicida
BRPI1008123A2 (pt) Gene de resistencia a herbicida
EP2461667A4 (fr) Plantes transgéniques à biomasse accrue
DK2289304T3 (da) Høstmaskine
BRPI0918784A2 (pt) catalisadores heterogêneos modelados
FR2919987B1 (fr) Sac a dos a suspension
EP2208728A4 (fr) Dérivé hétérocyclique à activité inhibitrice sur la 11 -hydroxystéroïde déshydrogénase de type i
BRPI0818605A2 (pt) Derivados de 1,3,4-tiadiazl espiro-condensados para inibir a atividade de ksp cinesima
DK2402364T3 (da) Et nonapeptid med anti-tumor aktivitet
FR2947930B1 (fr) Detection d'attachement usb
EP2503070A4 (fr) Ensemble élément d'injection
EP2518148A4 (fr) GÈNE Dro1 CONTRÔLANT LES CARACTÉRISTIQUES D'ENRACINEMENT PROFOND DE PLANTES ET UTILISATION DE CELLES-CI
EP2321412A4 (fr) Cultures transgéniques tolérantes au stress
EP2342657A4 (fr) Reconfiguration d'un modèle
DK2217581T3 (da) Substituerede cyclopentaner med prostaglandinaktivitet
BRPI0920265A2 (pt) Derivado de difluormetanossulfonanilada oticamente ativo e herbicida
EP2195432A4 (fr) Plantes ayant une biomasse accrue
EP2187729A4 (fr) Plantes génétiquement modifiées à inflorescence altérée

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: UNIVERSITE D'ANGERS, FR

Effective date: 20130808

Owner name: INSERM, FR

Effective date: 20130808

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11